The Prognostic Role of Tissue Characterisation using Cardiovascular Magnetic Resonance in Heart Failure

Robert D Adam1, James Shambrook1, Andrew S Flett1

  • 1Department of Cardiology, University Hospital Southampton,Southampton, UK.

Cardiac Failure Review
|February 2, 2018
PubMed

Insights

Cardiovascular magnetic resonance mapping improves heart failure risk stratification. Novel techniques offer deeper insights into disease mechanisms, aiding personalized therapy and improving patient outcomes.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Biomedical Engineering

Background:

  • Heart failure prognosis remains poor despite advances, with high mortality rates within a year of admission.
  • Current risk stratification and personalized therapy approaches are limited, often oversimplifying the complex nature of heart failure.
  • Left ventricular systolic function is a primary, yet insufficient, criterion for clinical trial enrollment and advanced therapy selection.

Purpose of the Study:

  • To review the prognostic evidence for novel cardiovascular magnetic resonance (CMR) mapping techniques in heart failure.
  • To highlight how CMR mapping can aid in diagnosis, prognostication, and understanding pathophysiological mechanisms.
  • To emphasize the potential of CMR mapping for personalized heart failure management.

Main Methods:

  • Review of existing literature on cardiovascular magnetic resonance (CMR) mapping techniques.
  • Analysis of prognostic data derived from advanced CMR mapping in heart failure patients.
  • Exploration of how CMR mapping visualizes pathophysiological substrates of heart failure.

Main Results:

  • Cardiovascular magnetic resonance (CMR) provides extensive data crucial for heart failure diagnosis and prognosis.
  • Novel CMR mapping techniques offer insights into the complex pathophysiological mechanisms of heart failure.
  • Evidence supports the use of CMR mapping for improved risk stratification and personalized treatment strategies.

Conclusions:

  • Cardiovascular magnetic resonance (CMR) mapping techniques are emerging as powerful tools in managing heart failure.
  • These advanced imaging methods enhance our understanding of heart failure pathophysiology, enabling better prognostication.
  • Personalized therapy guided by CMR mapping holds promise for improving outcomes in heart failure patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
402
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369